Effect of azithromycin and terbutaline on the improvement of clinical symptoms in children with pneumonia
10.3969/j.issn.1005-1678.2017.06.118
- VernacularTitle:阿奇霉素与特布他林对小儿肺炎临床症状改善情况的影响分析
- Author:
Chenhong LI
;
Zhiming DI
- Keywords:
Azithromycin;
terbutaline;
pneumonia;
inflammatory factor
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(6):312-314
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of Azithromycin combined with terbutaline on the treatment of pneumonia in children and its effect on symptom improvement.MethodsThe clinical data of children with pneumonia treated in Taizhou Hospital of traditional Chinese and Western medicine from January 2014 to December 2016 were retrospectively analyzed, according to the treatment methods,the patients were divided into control group and observation group, the control group was given azithromycin treatment, the observation group on this basis to give terbutaline atomization treatment.The therapeutic effects of the two groups were observed, and the differences of clinical symptom score, inflammatory factor level were compared between the two groups before and after treatment.ResultsThe effective rate of the observation group was 98%, which was significantly higher than that of the control group (84%);The clinical symptom score had no difference between the two groups before treatment, after treatment, the observation group of cough, expectoration, fever and rales were lower than those in the control group;The two groups had no difference between the levels of proinflammatory cytokines, after treatment, the observation group IL-6, IL-8, TNF-and CRP levels were lower than the control group.ConclusionAzithromycin combined with terbutaline in the treatment of children with pneumonia has a better therapeutic effect, can significantly improve the clinical symptoms, reduce the level of inflammatory factors, has a good clinical value.
